DE602006015358D1 - In-vitro-verfahren zum screening zugänglicher biologischer marker in krankhaften geweben - Google Patents
In-vitro-verfahren zum screening zugänglicher biologischer marker in krankhaften gewebenInfo
- Publication number
- DE602006015358D1 DE602006015358D1 DE602006015358T DE602006015358T DE602006015358D1 DE 602006015358 D1 DE602006015358 D1 DE 602006015358D1 DE 602006015358 T DE602006015358 T DE 602006015358T DE 602006015358 T DE602006015358 T DE 602006015358T DE 602006015358 D1 DE602006015358 D1 DE 602006015358D1
- Authority
- DE
- Germany
- Prior art keywords
- biological marker
- vitro process
- illuminated tissue
- accessible biological
- screening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000090 biomarker Substances 0.000 title abstract 2
- 238000000338 in vitro Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000012216 screening Methods 0.000 title 1
- 206010006187 Breast cancer Diseases 0.000 abstract 2
- 208000026310 Breast neoplasm Diseases 0.000 abstract 2
- 239000002243 precursor Substances 0.000 abstract 2
- 102000004154 Annexin A6 Human genes 0.000 abstract 1
- 108090000656 Annexin A6 Proteins 0.000 abstract 1
- 102100032059 EMILIN-1 Human genes 0.000 abstract 1
- 101710043324 EMILIN-1 Proteins 0.000 abstract 1
- 102000016753 Myoferlin Human genes 0.000 abstract 1
- 108050006329 Myoferlin Proteins 0.000 abstract 1
- 102100033523 Thy-1 membrane glycoprotein Human genes 0.000 abstract 1
- 101710094130 Thy-1 membrane glycoprotein Proteins 0.000 abstract 1
- 102000011405 Voltage-dependent anion-selective channel protein 3 Human genes 0.000 abstract 1
- 108050001626 Voltage-dependent anion-selective channel protein 3 Proteins 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06100141A EP1806587A1 (de) | 2006-01-07 | 2006-01-07 | In-vitro-Verfahren zum Screening zugänglicher biologischer Marker in pathologischen Geweben |
| PCT/EP2006/069679 WO2007080039A1 (en) | 2006-01-07 | 2006-12-13 | An in-vitro method for screening accessible biological markers in pathologic tissues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602006015358D1 true DE602006015358D1 (de) | 2010-08-19 |
Family
ID=36021803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602006015358T Active DE602006015358D1 (de) | 2006-01-07 | 2006-12-13 | In-vitro-verfahren zum screening zugänglicher biologischer marker in krankhaften geweben |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090163414A1 (de) |
| EP (3) | EP1806587A1 (de) |
| JP (1) | JP5089607B2 (de) |
| AT (1) | ATE473447T1 (de) |
| DE (1) | DE602006015358D1 (de) |
| WO (1) | WO2007080039A1 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130331294A1 (en) | 2007-11-09 | 2013-12-12 | Fox Chase Cancer Center | Egfr/nedd9/tgf-beta interactome and methods of use thereof for the identification of agents having efficacy in the treatment of hyperproliferative disorders |
| JP2011521215A (ja) | 2008-05-14 | 2011-07-21 | エーテーハー チューリヒ | 前立腺癌の診断及び治療のためのバイオマーカー及び薬剤標的発見法、並びにそれを用いて決定されるバイオマーカーアッセイ |
| EP2463658A1 (de) * | 2010-12-13 | 2012-06-13 | Université de Liège | Biomarker, Verwendungen von Biomarkern und Verfahren zur Identifizierung von Biomarkern |
| EP2463659A1 (de) * | 2010-12-13 | 2012-06-13 | Université de Liège | Biomarker für die Krebsdiagnose |
| CN112698025B (zh) * | 2020-12-14 | 2022-10-18 | 四川沃文特生物技术有限公司 | 抗原或抗体包被磁微粒的方法、应用及试剂盒 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5336506A (en) * | 1986-07-03 | 1994-08-09 | Advanced Magnetics Inc. | Targeting of therapeutic agents using polysaccharides |
| CA2409333A1 (en) | 2000-03-20 | 2001-09-27 | Anthony C. Stevens | Methods for identifying and isolating tissue-specific lumen-exposed molecules |
| WO2002059377A2 (en) * | 2001-01-24 | 2002-08-01 | Protein Design Labs | Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| US20070015148A1 (en) * | 2001-01-25 | 2007-01-18 | Orr Michael S | Gene expression profiles in breast tissue |
| CN1554025A (zh) * | 2001-03-12 | 2004-12-08 | Īŵ���ɷ�����˾ | 患病状态的细胞为基础的检测和鉴别 |
| US20040241160A1 (en) * | 2001-07-13 | 2004-12-02 | Yan Wu | Vegfr-1 antibodies to treat breast cancer |
| AU2002323120A1 (en) * | 2001-08-13 | 2003-03-03 | Dana-Farber Cancer Institute, Inc. | Periostin-based diagnostic assays |
| US7422865B2 (en) * | 2003-01-13 | 2008-09-09 | Agilent Technologies, Inc. | Method of identifying peptides in a proteomic sample |
| JP2005073621A (ja) * | 2003-09-01 | 2005-03-24 | Japan Science & Technology Agency | 脳腫瘍マーカーと脳腫瘍の診断方法 |
| CN1922490B (zh) * | 2004-02-19 | 2012-07-04 | 耶鲁大学 | 使用蛋白质组学技术鉴定癌症蛋白生物标志物的方法 |
| US20060178833A1 (en) * | 2005-02-04 | 2006-08-10 | Bauer Kenneth D | System for and method of providing diagnostic information through microscopic imaging |
-
2006
- 2006-01-07 EP EP06100141A patent/EP1806587A1/de not_active Withdrawn
- 2006-12-13 EP EP10164626A patent/EP2226638A3/de not_active Withdrawn
- 2006-12-13 DE DE602006015358T patent/DE602006015358D1/de active Active
- 2006-12-13 JP JP2008548958A patent/JP5089607B2/ja not_active Expired - Fee Related
- 2006-12-13 US US12/160,200 patent/US20090163414A1/en not_active Abandoned
- 2006-12-13 AT AT06830605T patent/ATE473447T1/de not_active IP Right Cessation
- 2006-12-13 EP EP06830605A patent/EP1969376B1/de not_active Not-in-force
- 2006-12-13 WO PCT/EP2006/069679 patent/WO2007080039A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| JP5089607B2 (ja) | 2012-12-05 |
| US20090163414A1 (en) | 2009-06-25 |
| EP2226638A2 (de) | 2010-09-08 |
| WO2007080039A1 (en) | 2007-07-19 |
| EP1806587A1 (de) | 2007-07-11 |
| EP2226638A3 (de) | 2010-12-15 |
| EP1969376B1 (de) | 2010-07-07 |
| JP2009522562A (ja) | 2009-06-11 |
| EP1969376A1 (de) | 2008-09-17 |
| ATE473447T1 (de) | 2010-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2459228A (en) | Exosome-associated microrna as a diagnostic marker | |
| PH12013502192A1 (en) | Antibodies against human angiopoietin 2 | |
| ITPD20050266A1 (it) | Apparato per il trattamento di patologie di origine malformativa e traumatica afferenti l'area del ginocchio | |
| CL2008000670A1 (es) | Compuestos derivados de tiazolidindionas y oxazolidindionas sustituidas; composicion farmaceutica; proceso de preparacion de la composicion farmaceutica; y uso en el tratamiento de enfermedades tales como artritis reumatoide, epoc, cancer, entre otras. | |
| SMT201600025B (it) | Composti di isoindolina per l'uso nel trattamento del cancro | |
| CL2008002107A1 (es) | Formas polimórficas del ácido 2-{2-cloro-5-{[(2s)-3-(5-cloro-1´h,3h-espiro[1-benzofuran-2,4'-piperidin]-1'-il)-2-hidroxipropil]oxi}-4-[(metilamino]carbonil]fenoxi}-2-metilpropanoico; proceso de preparacion; composición farmacéutica; dispositivo farmacéutico; y uso en el tratamiento de enfermedades respiratorias. | |
| MY153198A (en) | Inhibitors of protein aggregation | |
| IL217159A (en) | A device for separating protein from a tissue culture fluid stream | |
| CL2009000349A1 (es) | Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer. | |
| CL2008003730A1 (es) | Derivado de metastina ; profarmaco de dicho derivado; producto farmaceutico de dicho derivado; uso de dicho derivado para tratar metastasis de cancer o crecimiento del cancer. | |
| TW200716646A (en) | (S)-N-methylnaltrexone | |
| CL2011001313A1 (es) | Compuestos derivados de n-(fenil)-sulfonilamina, inhibidores de bcl2 o bcl-xl; composicion farmaceutica; y su uso en el tratamiento de cancer de vejiga, cerebro, mamas, medula osea, cervical, colorrectal, esofago, cancer hepatocelular, leucemia linfoblastica, linfoma folicular, mieloma. | |
| BRPI0817693A2 (pt) | Métodos e aparelho para iluminar ovos atráves de detecção de batimento cardíaco do embrião | |
| DOP2013000016A (es) | Formas cristalinas del dimetoxi-docetaxel y sus procedimientos de preparacion | |
| DE602005019762D1 (de) | Medizinisches Instrument zum Manipulieren, insbesondere zum Zurückziehen des Gewebes oder des Organes. | |
| UY31114A1 (es) | Anticuerpos humanizados contra el globulómero ab(20-42) y sus usos | |
| EP2464753A4 (de) | Bioerkennungsverfahren und -zusammensetzungen | |
| ATE538652T1 (de) | Synergistische pharmazeutische kombination für die behandlung von krebs | |
| DK2027152T3 (da) | Peptidfragmenter til induktion af syntese af ekstracellulære matrixproteiner | |
| TR201903026T4 (tr) | S100a4 anti̇korlari ve bunlarin terapöti̇k kullanimlari. | |
| DE602006015358D1 (de) | In-vitro-verfahren zum screening zugänglicher biologischer marker in krankhaften geweben | |
| CL2007002382A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento del cancer a la piel. | |
| EA201101531A1 (ru) | Способ лечения острого миелоидного лейкоза | |
| MY147634A (en) | New crystalline forms | |
| PA8806501A1 (es) | Triazolotriazinas y triazolopirazinas y su uso |